Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-030297

Chief Financial Officer sold 5,940 shares at $5.04 ($29,908)

From the SEC's structured data for this filing

Trades in this filing

Koppikar Utpal · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-08-16 Sale : show line 1 in the form −5,940 $5.04 $29,908 197,589 D
Open-market sales · 5,940 sh · avg $5.04 · $29,908
Loading xslF345X03/form4.xml…